Search Results - "Lee, Agnes Y.Y"

Refine Results
  1. 1

    Hemophagocytic syndromes (HPS) including Hemophagocytic Lymphohistiocytosis (HLH) in Adults: A Systematic Scoping Review by Hayden, Anna, Park, Sujin, Giustini, Dean, Lee, Agnes Y.Y, Chen, Luke Y.C

    Published in Blood reviews (01-11-2016)
    “…Abstract Most knowledge of hemophagocytic syndromes (HPS) including hemophagocytic lymphohistiocytosis (HLH) is derived from pediatric studies; literature on…”
    Get full text
    Journal Article
  2. 2

    Venous thromboembolism and cancer: risks and outcomes by Lee, Agnes Y Y, Levine, Mark N

    Published in Circulation (New York, N.Y.) (17-06-2003)
    “…Cancer and its treatments are well-recognized risk factors for venous thromboembolism (VTE). Evidence suggests that the absolute risk depends on the tumor…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Anticoagulant Therapy for Venous Thromboembolism in Cancer by Lee, Agnes Y.Y

    Published in The New England journal of medicine (23-04-2020)
    “…Direct oral anticoagulants were introduced for the treatment for acute venous thromboembolism just over a decade ago. Unlike warfarin, these drugs are given in…”
    Get full text
    Journal Article
  5. 5

    Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape by Lee, Agnes Y.Y.

    Published in Bleeding, Thrombosis and Vascular Biology (29-02-2024)
    “…Cancer is a leading cause of morbidity and mortality worldwide. It is also one of the strongest risk factors for venous thromboembolism (VTE), reported in…”
    Get full text
    Journal Article
  6. 6

    Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients by Carrier, Marc, Lee, Agnes Y.Y, Bates, Shannon M, Anderson, David R, Wells, Philip S

    Published in Thrombosis research (2008)
    “…Abstract Introduction Deep vein thrombosis (DVT) can be safely and reliably excluded in patients with a low clinical probability and a negative D-dimer result…”
    Get full text
    Journal Article
  7. 7

    Efficacy and Safety of Anticoagulant Therapy for the Treatment of Acute Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis by Carrier, Marc, Cameron, Chris, Delluc, Aurélien, Castellucci, Lana, Khorana, Alok A, Lee, Agnes Y.Y

    Published in Thrombosis research (01-12-2014)
    “…Abstract Background Current clinical practice guidelines all recommend the use of therapeutic doses of low molecular weight heparins (LMWH) for the initial and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Anticoagulation in the Treatment of Established Venous Thromboembolism in Patients With Cancer by Lee, Agnes Y Y

    Published in Journal of clinical oncology (10-10-2009)
    “…Cancer-associated thrombosis is a frequent and costly complication in patients with cancer. Significant morbidity and mortality not only result from thrombotic…”
    Get full text
    Journal Article
  10. 10

    Treatment of cancer-associated thrombosis: perspectives on the use of novel oral anticoagulants by Lee, Agnes Y.Y, Carrier, Marc

    Published in Thrombosis research (01-05-2014)
    “…ABSTRACT Therapeutic options for the management of venous thromboembolism have expanded with the introduction of novel oral anticoagulants (NOACs). These…”
    Get full text
    Journal Article
  11. 11

    Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer by Lee, Agnes Y.Y, Levine, Mark N, Baker, Ross I, Bowden, Chris, Kakkar, Ajay K, Prins, Martin, Rickles, Frederick R, Julian, Jim A, Haley, Susan, Kovacs, Michael J, Gent, Michael

    Published in The New England journal of medicine (10-07-2003)
    “…Secondary prophylaxis against recurrent deep-vein thrombosis is important in patients with cancer, since these patients have an increased risk of recurrence…”
    Get full text
    Journal Article
  12. 12

    Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism by Lee, Agnes Y Y, Rickles, Frederick R, Julian, Jim A, Gent, Michael, Baker, Ross I, Bowden, Chris, Kakkar, Ajay K, Prins, Martin, Levine, Mark N

    Published in Journal of clinical oncology (01-04-2005)
    “…Experimental studies and indirect clinical evidence suggest that low molecular weight heparins may have antineoplastic effects. We investigated the influence…”
    Get full text
    Journal Article
  13. 13

    Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer by LEE, Agnes Y. Y, LEVINE, Mark N, BUTLER, Gregory, WEBB, Carolyn, COSTANTINI, Lorrie, CHUSHU GU, JULIAN, Jim A

    Published in Journal of clinical oncology (20-03-2006)
    “…Thrombosis of long-term central venous catheters (CVC) is a serious complication that causes morbidity and interrupts the infusion of chemotherapy, intravenous…”
    Get full text
    Journal Article
  14. 14

    Treatment of established thrombotic events in patients with cancer by Lee, Agnes Y.Y

    Published in Thrombosis research (01-04-2012)
    “…Abstract Acutely ill medical patients with cancer and cancer patients requiring Anticoagulants remain the cornerstone of therapy for venous thromboembolism. In…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging by Chan, Wee-Shian, Spencer, Frederick A, Lee, Agnes Y Y, Chunilal, Sanjeev, Douketis, James D, Rodger, Marc, Ginsberg, Jeffrey S

    “…Compression ultrasonography performed serially over a 7-day period is recommended for the diagnosis of deep vein thrombosis in symptomatic pregnant women, but…”
    Get full text
    Journal Article
  17. 17

    Management of anticoagulation for cancer‐associated thrombosis in patients with thrombocytopenia: A systematic review by Samuelson Bannow, Bethany R., Lee, Agnes Y.Y., Khorana, Alok A., Zwicker, Jeffrey I., Noble, Simon, Ay, Cihan, Carrier, Marc

    “…Unlabelled Box The management of anticoagulation for cancer‐associated thrombosis (CAT) in patients with thrombocytopenia is controversial. Whereas some…”
    Get full text
    Journal Article
  18. 18

    Clinical practice guidelines on cancer-associated thrombosis: a review on scope and methodology by Lee, Agnes Y.Y, Peterson, Erica A, Wu, Cynthia

    Published in Thrombosis research (01-04-2016)
    “…ABSTRACT Cancer-associated thrombosis is a well-recognized complication in patients with cancer. It imposes significant patient morbidity and anxiety,…”
    Get full text
    Journal Article
  19. 19

    Dual direct oral anticoagulant therapy in challenging thrombosis: a case series by Chornenki, Nicholas L.J., McPhaden, Heather, Peterson, Erica A., Benjamin Lai, Chieh Min, Lee, Agnes Y.Y.

    “…While anticoagulation therapy is highly effective at treating venous thromboembolism, some patients can develop rapidly progressive thrombosis in multiple…”
    Get full text
    Journal Article
  20. 20